Foreign establishment registration
FDA plans to prohibit importation of drugs from foreign manufacturers that are not listed with the agency under its proposed rule for Foreign Establishment Registration and Listing, published May 14. The rule, mandated by the FDA Modernization Act, would require foreign drug establishments to register with FDA, list all of their imported products, and to identify a U.S. agent
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth